Series A · $50M Target · USD-Denominated
Investor Relations
Building Africa's cancer intelligence infrastructure — raising $50M to deploy at continental scale.
Disclaimer: All financial figures are internal projections. They do not represent current operating results or constitute a guarantee of future performance.
Key Metrics
$50M
Series A Target
77%
Gross Margin / Scan
1.4B+
Addressable Lives
Y2 Q2
EBITDA Positive
Financial Projections
5-Year Revenue Table
| Year | Revenue (USD) | EBITDA | EBITDA Margin | Milestone |
|---|---|---|---|---|
| Year 1 | $4.9M | ($0.7M) | — | SA pilot live. First insurer billing. |
| Year 2 | $14.8M | $2.9M | 20% | EBITDA positive Q2. SADC entry begins. |
| Year 3 | $37.5M | $17.2M | 46% | Multi-cancer devices. Enterprise SaaS live. |
| Year 4 | $74.6M | $38.1M | 51% | IPO preparation. Pharma licensing. |
| Year 5 | $131.4M | $71.9M | 55%+ | JSE IPO / NASDAQ ADR / strategic sale. |
$50M Deployment
| Category | Amount | % | Purpose |
|---|---|---|---|
| 📱 Devices | $20M | 40% | 200+ iBreastExam™ units. Revenue from Month 1. |
| 🧠 Platform & AI | $12.5M | 25% | MedOS™ + MedIntelligence™ + HealthPass™. |
| 🚐 Pink Pulse™ | $7.5M | 15% | 25 mobile units: vehicles, fit-out, solar, satellite. |
| 👥 Executive Team | $5M | 10% | CMO, CTO, CFO, CCO, COO. |
| ⚖️ Regulatory | $2.5M | 5% | SAHPRA, MCAZ, CDH across 3 countries. |
| 🏦 Working Capital | $2.5M | 5% | 18+ months buffer. No second raise needed. |
Exit Scenarios
JSE Main Board IPO
R2.8B ~$151M
Year 4–5 · 11–15× on $50M · Primary exit path
Strategic Acquisition
$350M–$600M
Year 3–4 · Data premium · Pharma / Big Tech buyer
NASDAQ ADR
~$3.4B
Year 5–6 · Up to 68× · Health data SaaS multiples
Investor Resources
📊
Pitch Deck
Full 15-slide Series A investor presentation. Available to qualified investors.
Request Access📈
Financial Model
5-year quarterly projections. Revenue mix. Unit economics. Sensitivity analysis.
Request Access📋
Investor Brief 2.0
USA-targeted executive brief. All figures USD. Full addendum pack included.
Request Access
Qualified institutional investors may request the full data room via
investors@mandierahealth.tech
Contact Investor Relations
📧 investors@mandierahealth.tech
+27 76 655 1456 (WhatsApp)
Atrium on 5th, 5th Street, Sandton 2196, Johannesburg
Scan to open investor contact